background 9

The Antibody Discovery Specialists.

We are antibody enthusiasts working to discover biologics that target the most challenging classes of reagent and therapeutic targets.

 

Learn about our platform

Twist announcement banner3

 

 

Twist announcement banner mobile
antibody_whitebgrd
 
PARTNER WITH US

100+ Successful mAb Discovery Campaigns Targeting Cell Surface receptors.

Industry-leading solutions for therapeutic and reagent antibody developers. We have built a strong reputation on our ability to deliver outstanding science. We have custom-built gene-to-antibody solutions to support development efforts for:
  • Therapeutic antibodies against difficult targets such as GPCR, ion channels, glycan targets
  • Cell therapies
  • Point-of-care diagnostics
  • Reagent & anti-idiotypic antibodies supporting clinical trials
  • Anywhere else antibodies are needed

 

Expertise in Antibody Discovery

Industry leading platform for challenging target

 

GPCR-1Cell surface-1High homology-2

Anti-id-1cross reactive-2Functional antibodies

 

 

End-to-End Antibody Discovery Technologies

 

Core mAb Discovery_4

 

The Reviews Are In.

Pharma and biotech of various sizes and pipelines rely on Abveris.

"Our platform rapidly generates and validates new targets for treating challenging cancers. Working with Abveris will enable us to quickly identify and select highly specific antibodies for those targets, so that we can take the best antibody forward to address the needs of particular patient populations."

 

Jeff Goldberg

CEO

Immunitas Therapeutics

Speak with Abveris scientists about how to tackle challenges in antibody discovery.

Abveris News